PUBLIC COMPANY
saveHyloris Pharmaceuticals SA
updated 21d ago
community read0 votes
pipeline
8
marketed
1
phase 3
1
catalysts ytd
2
approvals ytd
1
recalls ytd
0
Pipeline(8)
pipeline depth8 products
2Preclinical3Phase 11Phase 21Phase 31Marketed
Marketed
METOLAZONE
Congestive Heart Failure (Heart Failure)
Phase 3tranexamic acid
Bleeding And Clotting Disorders
Plasminogen
Phase 2milrinone ER
Congestive Heart Failure (Heart Failure)
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A
Phase 1HY-083
Non Allergic Rhinitis
Phase 1atomoxetine
Attention Deficit Hyperactivity Disorder (ADHD)
Phase 1dofetilide
Atrial Fibrillation
Voltage-gated inwardly rectifying potassium channel KCNH2
PreclinicalHY-074
Acute Coronary Syndrome
PreclinicalHY-075
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that